Guangdong Zhongsheng Pharmaceutical Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Guangdong Zhongsheng Pharmaceutical kazanç ve gelirin sırasıyla yıllık 41.7% ve 16.3% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 41.2% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 8.7% olacağı tahmin edilmektedir.

Anahtar bilgiler

41.7%

Kazanç büyüme oranı

41.2%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi	18.8%
Gelir büyüme oranı	16.3%
Gelecekteki özkaynak getirisi	8.7%
Analist kapsamı	Low
Son güncelleme	21 Nov 2024

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings

Nov 04

Investor Optimism Abounds Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE:002317) But Growth Is Lacking

Oct 07

These 4 Measures Indicate That Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Is Using Debt Reasonably Well

Jul 12

Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) P/E Is On The Mark

Jun 18

Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Has Affirmed Its Dividend Of CN¥0.20

May 20

We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings

Apr 29

Does Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Have A Healthy Balance Sheet?

Mar 18

Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) Shares Climb 29% But Its Business Is Yet to Catch Up

Feb 29

Kazanç ve Gelir Büyüme Tahminleri

SZSE:002317 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	3,608	431	N/A	320	1
12/31/2025	3,121	362	N/A	292	1
12/31/2024	2,732	244	N/A	158	1
9/30/2024	2,447	133	219	435	N/A
6/30/2024	2,493	142	98	340	N/A
3/31/2024	2,505	175	-36	257	N/A
12/31/2023	2,611	263	-172	191	N/A
9/30/2023	2,756	353	-446	-21	N/A
6/30/2023	2,833	328	-447	-37	N/A
3/31/2023	2,747	387	-466	-108	N/A
1/1/2023	2,676	322	-205	63	N/A
9/30/2022	2,597	213	241	441	N/A
6/30/2022	2,545	192	411	617	N/A
3/31/2022	2,489	295	400	598	N/A
1/1/2022	2,429	278	409	623	N/A
9/30/2021	2,409	-414	-97	100	N/A
6/30/2021	2,321	-330	-150	13	N/A
3/31/2021	2,122	-423	-27	126	N/A
12/31/2020	1,896	-427	-16	139	N/A
9/30/2020	1,923	251	181	323	N/A
6/30/2020	2,010	207	189	336	N/A
3/31/2020	2,307	244	95	240	N/A
12/31/2019	2,532	318	123	251	N/A
9/30/2019	2,538	454	220	356	N/A
6/30/2019	2,474	464	320	455	N/A
3/31/2019	2,378	439	325	449	N/A
12/31/2018	2,362	436	183	327	N/A
9/30/2018	2,306	455	229	381	N/A
6/30/2018	2,197	447	N/A	274	N/A
3/31/2018	2,125	432	N/A	192	N/A
12/31/2017	1,964	420	N/A	370	N/A
9/30/2017	1,855	427	N/A	223	N/A
6/30/2017	1,837	439	N/A	230	N/A
3/31/2017	1,713	432	N/A	297	N/A
12/31/2016	1,692	414	N/A	338	N/A
9/30/2016	1,673	380	N/A	274	N/A
6/30/2016	1,640	371	N/A	351	N/A
3/31/2016	1,668	325	N/A	334	N/A
12/31/2015	1,578	297	N/A	192	N/A
9/30/2015	1,494	276	N/A	356	N/A
6/30/2015	1,433	257	N/A	219	N/A
3/31/2015	1,367	238	N/A	75	N/A
12/31/2014	1,309	225	N/A	101	N/A
9/30/2014	1,234	219	N/A	96	N/A
6/30/2014	1,190	211	N/A	97	N/A
3/31/2014	1,117	194	N/A	144	N/A
12/31/2013	1,090	188	N/A	111	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 002317 'nin tahmini kazanç büyümesi (yıllık 41.7% ) tasarruf oranının ( 2.8% ) üzerindedir.

Kazançlar ve Piyasa: 002317 şirketinin kazançlarının (yıllık 41.7% ) CN pazarından (yıllık 26.2% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 002317 şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: 002317 şirketinin gelirinin (yıllık 16.3% ) CN pazarından (yıllık 13.9% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 002317 şirketinin gelirinin (yıllık 16.3% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 002317 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 8.7 %).

Guangdong Zhongsheng Pharmaceutical Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings

Third quarter 2024 earnings released: EPS: CN¥0.084 (vs CN¥0.082 in 3Q 2023)

Investor sentiment deteriorates as stock falls 16%

Investor Optimism Abounds Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE:002317) But Growth Is Lacking

Guangdong Zhongsheng Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

These 4 Measures Indicate That Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Is Using Debt Reasonably Well

Guangdong Zhongsheng Pharmaceutical Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) P/E Is On The Mark

Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Has Affirmed Its Dividend Of CN¥0.20

Dividend of CN¥0.20 announced

We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Guangdong Zhongsheng Pharmaceutical Co., Ltd., Annual General Meeting, May 14, 2024

Guangdong Zhongsheng Pharmaceutical Co., Ltd. to Report Q1, 2024 Results on Apr 23, 2024

Does Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Have A Healthy Balance Sheet?

Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) Shares Climb 29% But Its Business Is Yet to Catch Up

Investor sentiment improves as stock rises 27%

Investor sentiment deteriorates as stock falls 17%

Guangdong Zhongsheng Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 23, 2024

Investor sentiment improves as stock rises 15%

Third quarter 2023 earnings released: EPS: CN¥0.082 (vs CN¥0.059 in 3Q 2022)

Investor sentiment deteriorates as stock falls 17%

New minor risk - Share price stability

Investor sentiment improves as stock rises 15%

Second quarter 2023 earnings released: EPS: CN¥0.088 (vs CN¥0.16 in 2Q 2022)

Guangdong Zhongsheng Pharmaceutical Co., Ltd. to Report First Half, 2023 Results on Aug 22, 2023

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 16 May 2023

Investor sentiment deteriorates as stock falls 20%

Full year 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.35 in FY 2021)

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announces Board Elections

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.059 (vs CN¥0.032 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.29 in 2Q 2021)

Guangdong Zhongsheng Pharmaceutical Co., Ltd. announced that it expects to receive CNY 678.8 million in funding

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announces Cash Dividend, Payable on May 27, 2022

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2021

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021

High number of new and inexperienced directors

Third quarter 2021 earnings released: EPS CN¥0.032 (vs CN¥0.14 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.17 in 2Q 2020)

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2020

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announces Final Profit Distribution Proposal for 2020

First quarter 2021 earnings released: EPS CN¥0.07 (vs CN¥0.07 in 1Q 2020)

New 90-day low: CN¥8.13

New 90-day low: CN¥9.73

New 90-day low: CN¥12.06

New 90-day low: CN¥12.11

Third quarter earnings released

New 90-day low: CN¥13.12

Guangdong Zhongsheng Pharmaceutical Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020

New 90-day low: CN¥14.14

Shanghai Yongwei Biotechnology Co., Ltd. completed the acquisition of Guangdong Zhongqiang Pharmaceutical Co., Ltd. from Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE:002317).

Earnings released

Guangdong Zhongsheng Pharmaceutical Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin